Assessing the Effects of Parthenolide on Inflammation, Bone Loss, and Glial Cells within a Collagen Antibody-Induced Arthritis Mouse Model

Rheumatoid arthritis is characterised by a chronic inflammatory response resulting in destruction of the joint and significant pain. Although a range of treatments are available to control disease activity in RA, bone destruction and joint pain exist despite suppression of inflammation. This study i...

Full description

Saved in:
Bibliographic Details
Main Authors: B. Williams, F. Lees, H. Tsangari, M. R. Hutchinson, E. Perilli, T. N. Crotti
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2020/6245798
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849694057308094464
author B. Williams
F. Lees
H. Tsangari
M. R. Hutchinson
E. Perilli
T. N. Crotti
author_facet B. Williams
F. Lees
H. Tsangari
M. R. Hutchinson
E. Perilli
T. N. Crotti
author_sort B. Williams
collection DOAJ
description Rheumatoid arthritis is characterised by a chronic inflammatory response resulting in destruction of the joint and significant pain. Although a range of treatments are available to control disease activity in RA, bone destruction and joint pain exist despite suppression of inflammation. This study is aimed at assessing the effects of parthenolide (PAR) on paw inflammation, bone destruction, and pain-like behaviour in a mild collagen antibody-induced arthritis (CAIA) mouse model. CAIA was induced in BALB/c mice and treated daily with 1 mg/kg or 4 mg/kg PAR. Clinical paw inflammation was scored daily, and mechanical hypersensitivity was assessed on alternate days. At end point, bone volume and swelling in the paws were assessed using micro-CT. Paw tissue sections were assessed for inflammation and pre-/osteoclast-like cells. The lumbar spinal cord and the periaqueductal grey (PAG) and rostral ventromedulla (RVM) regions of the brain were stained for glial fibrillary acidic protein (GFAP) and ionised calcium-binding adaptor molecule 1 (IBA1) to assess for glial reactivity. Paw scores increased in CAIA mice from days 5-10 and were reduced with 1 mg/kg and 4 mg/kg PAR on days 8-10. Osteoclast-like cells on the bone surface of the radiocarpal joint and within the soft tissue of the hind paw were significantly lower following PAR treatment (p<0.005). GFAP- and IBA1-positive cells in the PAG and RVM were significantly lower following treatment with 1 mg/kg (p<0.0001 and p=0.0004, respectively) and 4 mg/kg PAR (p<0.0001 and p=0.001, respectively). In the lumbar spinal cord, IBA1-positive cells were significantly lower in CAIA mice treated with 4 mg/kg PAR (p=0.001). The findings indicate a suppressive effect of both low- and moderate-dose PAR on paw inflammation, osteoclast presence, and glial cell reactivity in a mild CAIA mouse model.
format Article
id doaj-art-49cdf2d2f0984e5f9ae5a6b24f72aa0a
institution DOAJ
issn 0962-9351
1466-1861
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-49cdf2d2f0984e5f9ae5a6b24f72aa0a2025-08-20T03:20:13ZengWileyMediators of Inflammation0962-93511466-18612020-01-01202010.1155/2020/62457986245798Assessing the Effects of Parthenolide on Inflammation, Bone Loss, and Glial Cells within a Collagen Antibody-Induced Arthritis Mouse ModelB. Williams0F. Lees1H. Tsangari2M. R. Hutchinson3E. Perilli4T. N. Crotti5Adelaide Medical School, University of Adelaide, Adelaide SA, 5005, AustraliaAdelaide Medical School, University of Adelaide, Adelaide SA, 5005, AustraliaAdelaide Medical School, University of Adelaide, Adelaide SA, 5005, AustraliaAdelaide Medical School, University of Adelaide, Adelaide SA, 5005, AustraliaMedical Device Research Institute, College of Science and Engineering, Flinders University, Tonsley SA, 5042, AustraliaAdelaide Medical School, University of Adelaide, Adelaide SA, 5005, AustraliaRheumatoid arthritis is characterised by a chronic inflammatory response resulting in destruction of the joint and significant pain. Although a range of treatments are available to control disease activity in RA, bone destruction and joint pain exist despite suppression of inflammation. This study is aimed at assessing the effects of parthenolide (PAR) on paw inflammation, bone destruction, and pain-like behaviour in a mild collagen antibody-induced arthritis (CAIA) mouse model. CAIA was induced in BALB/c mice and treated daily with 1 mg/kg or 4 mg/kg PAR. Clinical paw inflammation was scored daily, and mechanical hypersensitivity was assessed on alternate days. At end point, bone volume and swelling in the paws were assessed using micro-CT. Paw tissue sections were assessed for inflammation and pre-/osteoclast-like cells. The lumbar spinal cord and the periaqueductal grey (PAG) and rostral ventromedulla (RVM) regions of the brain were stained for glial fibrillary acidic protein (GFAP) and ionised calcium-binding adaptor molecule 1 (IBA1) to assess for glial reactivity. Paw scores increased in CAIA mice from days 5-10 and were reduced with 1 mg/kg and 4 mg/kg PAR on days 8-10. Osteoclast-like cells on the bone surface of the radiocarpal joint and within the soft tissue of the hind paw were significantly lower following PAR treatment (p<0.005). GFAP- and IBA1-positive cells in the PAG and RVM were significantly lower following treatment with 1 mg/kg (p<0.0001 and p=0.0004, respectively) and 4 mg/kg PAR (p<0.0001 and p=0.001, respectively). In the lumbar spinal cord, IBA1-positive cells were significantly lower in CAIA mice treated with 4 mg/kg PAR (p=0.001). The findings indicate a suppressive effect of both low- and moderate-dose PAR on paw inflammation, osteoclast presence, and glial cell reactivity in a mild CAIA mouse model.http://dx.doi.org/10.1155/2020/6245798
spellingShingle B. Williams
F. Lees
H. Tsangari
M. R. Hutchinson
E. Perilli
T. N. Crotti
Assessing the Effects of Parthenolide on Inflammation, Bone Loss, and Glial Cells within a Collagen Antibody-Induced Arthritis Mouse Model
Mediators of Inflammation
title Assessing the Effects of Parthenolide on Inflammation, Bone Loss, and Glial Cells within a Collagen Antibody-Induced Arthritis Mouse Model
title_full Assessing the Effects of Parthenolide on Inflammation, Bone Loss, and Glial Cells within a Collagen Antibody-Induced Arthritis Mouse Model
title_fullStr Assessing the Effects of Parthenolide on Inflammation, Bone Loss, and Glial Cells within a Collagen Antibody-Induced Arthritis Mouse Model
title_full_unstemmed Assessing the Effects of Parthenolide on Inflammation, Bone Loss, and Glial Cells within a Collagen Antibody-Induced Arthritis Mouse Model
title_short Assessing the Effects of Parthenolide on Inflammation, Bone Loss, and Glial Cells within a Collagen Antibody-Induced Arthritis Mouse Model
title_sort assessing the effects of parthenolide on inflammation bone loss and glial cells within a collagen antibody induced arthritis mouse model
url http://dx.doi.org/10.1155/2020/6245798
work_keys_str_mv AT bwilliams assessingtheeffectsofparthenolideoninflammationbonelossandglialcellswithinacollagenantibodyinducedarthritismousemodel
AT flees assessingtheeffectsofparthenolideoninflammationbonelossandglialcellswithinacollagenantibodyinducedarthritismousemodel
AT htsangari assessingtheeffectsofparthenolideoninflammationbonelossandglialcellswithinacollagenantibodyinducedarthritismousemodel
AT mrhutchinson assessingtheeffectsofparthenolideoninflammationbonelossandglialcellswithinacollagenantibodyinducedarthritismousemodel
AT eperilli assessingtheeffectsofparthenolideoninflammationbonelossandglialcellswithinacollagenantibodyinducedarthritismousemodel
AT tncrotti assessingtheeffectsofparthenolideoninflammationbonelossandglialcellswithinacollagenantibodyinducedarthritismousemodel